13F Filings History of BP PLC

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • BP PLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • BP PLC reported 1 equity holding with a total reported market value of $17,721,000 for Q1 2026.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Andy Zone - Senior Finance Manager
Manager location
London, United Kingdom

Follow Filing Activity

Follow BP PLC and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q1 2026
Latest value
$17,721,000
Quarter delta
+$926,400
Accepted
08 May 2026, 13:23
Rows shown
1-25 of 54
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q1 2026 1 $17,721,000 $0 $0 $0 CME 13F-HR 08 May 2026, 13:23
Q4 2025 1 $16,794,600 $0 $0 $0 CME 13F-HR 11 Feb 2026, 12:43
Q3 2025 1 $15,929,400 $0 -$345,655 -$345,655 CME 13F-HR 06 Nov 2025, 12:57
Q2 2025 2 $16,882,855 +$345,655 $0 +$345,655 CME, PONY 13F-HR 07 Aug 2025, 09:32
Q1 2025 1 $15,917,000 $0 $0 $0 CME 13F-HR 01 May 2025, 13:46
Q4 2024 1 $13,933,800 $0 $0 $0 CME 13F-HR 10 Feb 2025, 08:31
Q3 2024 1 $13,239,000 $0 -$1,852,000 -$1,852,000 CME 13F-HR 08 Nov 2024, 08:53
Q2 2024 2 $13,648,000 $0 $0 $0 CME, DOCS 13F-HR 08 Aug 2024, 11:14
Q1 2024 2 $14,699,000 $0 $0 $0 CME, DOCS 13F-HR 09 May 2024, 10:21
Q4 2023 2 $14,493,000 $0 $0 $0 CME, DOCS 13F-HR 09 Feb 2024, 11:35
Q3 2023 3 $13,418,000 $0 $0 $0 CME, DOCS 13F-HR 13 Nov 2023, 07:32
Q2 2023 3 $13,490,000 +$120,000 -$1,455,000 -$1,335,000 CME, DOCS, OLO 13F-HR 10 Aug 2023, 10:42
Q1 2023 4 $15,090,000 +$1,455,000 -$345,000 +$1,110,000 CME, DOCS, HCP, PATH 13F-HR 10 May 2023, 08:20
Q4 2022 3 $12,658,000 +$345,000 -$881,251 -$536,251 CME, DOCS, NU 13F-HR 08 Feb 2023, 08:39
Q3 2022 2 $13,422,000 $0 $0 $0 CME, DOCS 13F-HR 04 Nov 2022, 10:40
Q2 2022 5 $0 $0 $0 $0 13F-HR 04 Aug 2022, 06:16
Q1 2022 4 $18,113,000 $0 -$1,540,897 -$1,540,897 CME, DOCS, PDD, EPZM 13F-HR 11 May 2022, 06:46
Q4 2021 5 $19,107,000 +$4,809,000 -$5,245,090 -$436,090 CME, DOCS, PDD, DADA, EPZM 13F-HR 09 Feb 2022, 09:07
Q3 2021 5 $18,301,000 +$4,333,000 -$2,319,979,056 -$2,315,646,056 CME, WRBY, PDD, OLO, EPZM 13F-HR 10 Nov 2021, 13:49
Q2 2021 579 $2,336,364,000 +$110,448,903 -$864,318,483 -$753,869,580 MSFT, ADBE, AMZN, GOOG, AAPL 13F-HR 09 Aug 2021, 12:16
Q1 2021 580 $2,855,386,000 +$157,918,021 -$748,703,768 -$590,785,747 MSFT, AMZN, ADBE, GOOG, AAPL 13F-HR 13 May 2021, 10:56
Q4 2020 550 $3,303,399,000 +$154,339,881 -$1,427,524,631 -$1,273,184,750 MSFT, AMZN, ADBE, AAPL, GOOG 13F-HR 08 Feb 2021, 15:53
Q3 2020 516 $4,126,376,000 +$1,629,053,092 -$336,568,190 +$1,292,484,902 MSFT, AMZN, AAPL, ADBE, BABA 13F-HR 30 Oct 2020, 17:05
Q2 2020 532 $2,740,398,000 +$120,267,373 -$173,200,312 -$52,932,939 MSFT, AAPL, AMZN, BABA, META 13F-HR 05 Aug 2020, 11:02
Q1 2020 505 $2,334,025,000 +$150,114,687 -$233,347,608 -$83,232,921 MSFT, AAPL, AMZN, BABA, META 13F-HR 05 May 2020, 15:21
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .